
Albireo Pharma ALBO
Quarterly report 2022-Q3
added 11-08-2022
Albireo Pharma P/S Ratio 2011-2026 | ALBO
Annual P/S Ratio Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.3 | 84.2 | 28.2 | 22.3 | 278 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 278 K | 13.3 | 55.5 K |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.41 | -1.4 % | $ 2.57 B | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.79 | -6.51 % | $ 4.31 M | ||
|
Axsome Therapeutics
AXSM
|
13.6 | $ 165.07 | -0.79 % | $ 8.21 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.76 | -1.7 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 8.57 | -1.83 % | $ 1.4 B | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Capricor Therapeutics
CAPR
|
6.17 | $ 26.36 | -1.82 % | $ 706 M | ||
|
Certara
CERT
|
2.57 | $ 7.24 | 2.62 % | $ 1.16 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
4.91 | $ 1.01 | -0.98 % | $ 74.1 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
5.16 | $ 23.77 | -0.46 % | $ 2.91 B | ||
|
Agenus
AGEN
|
0.00137 | $ 3.27 | -2.09 % | $ 1.17 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
30.2 | $ 28.85 | -1.2 % | $ 1.67 B | ||
|
Champions Oncology
CSBR
|
1.86 | $ 5.98 | -1.48 % | $ 81.7 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
1.28 | - | - | - | ||
|
Фармсинтез
LIFE
|
5.39 | - | - | - | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 3.71 | -2.43 % | $ 116 M | ||
|
Alector
ALEC
|
11.7 | $ 2.13 | -3.39 % | $ 219 M | ||
|
Altimmune
ALT
|
23.1 K | $ 4.22 | 1.32 % | $ 300 M | ||
|
Teligent, Inc.
TLGT
|
0.111 | - | -13.85 % | $ 16.1 M | ||
|
Viela Bio, Inc.
VIE
|
36.6 | - | - | $ 2.91 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Amarin Corporation plc
AMRN
|
27.2 | $ 14.3 | 2.66 % | $ 5.93 B | ||
|
AbbVie
ABBV
|
24.1 | $ 233.44 | -0.33 % | $ 413 B |